skip navigationU S P T O SealUnited States Patent and Trademark Office TTABVUE logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
TTABVUE. Trademark Trial and Appeal Board Inquiry System
v1.9

Summary

Query: Party Name contains all words: IPSEN S.A.
Number of results: 31
Results are in reverse chronological order

Page #1. 2 Next
Proceeding
Filing Date
Defendant(s),
Property(ies)
Plaintiff(s),
Property(ies)
91250766
09/04/2019
Ipsen Pharma S.A.S.
Mark: ACROMUNITY S#:79237547
Helix OpCo, LLC
Mark: HELIX S#:87539101 R#:5846056
Mark: HELIX S#:87573883 R#:5846086
79237547
06/05/2019
IPSEN PHARMA S.A.S.
Mark: ACROMUNITY S#:79237547
Helix OpCo, LLC
87263764
10/25/2018
Ipsen S.A.
Mark: IPSEN S#:87263764
87637560
10/11/2018
IPSEN PHARMA S.A.S.
Mark: AIRGLOW S#:87637560
Ferton Holding S.A.
91231052
11/07/2016
Ipsen Pharma S.A.S.
Mark: FORLAX S#:86851032
Glaxo Group Limited
Mark: FORTAZ S#:73376990 R#:1286762
86851032
06/06/2016
Ipsen Pharma S.A.S.
Mark: FORLAX S#:86851032
Glaxo Group Limited
91223890
09/18/2015
LSI Medience Corporation
S#:86268259
Ipsen S.A.
Mark: IPSEN S#:79002056 R#:3251886
86549047
08/27/2015
INTRANERVE
Mark: INNOVATIVE DIFFERENCE IN PATIENT CARE S#:86549047
Ipsen S.A.
86268259
04/13/2015
LSI Medience Corporation
S#:86268259
Ipsen S.A.
91220338
01/26/2015
Somahlution, LLC
Mark: SOMAHLUTION S#:86248574
Ipsen Pharma S.A.S.
Mark: SOMATULINE S#:74532825 R#:2286865
Mark: SOMATULINE S#:75789007 R#:2524021
91218333
09/15/2014
Case Western Reserve University
Mark: ISENS S#:86100584
Ipsen S.A.
Mark: IPSEN S#:79002058 R#:3245038
91218331
09/15/2014
Case Western Reserve University
Mark: ISENS S#:86100571
Ipsen S.A.
Mark: IPSEN S#:79002058 R#:3245038
86248574
08/25/2014
Somahlution, LLC
Mark: SOMAHLUTION S#:86248574
Ipsen Pharma S.A.S.
86100584
04/15/2014
Case Western Reserve University
Mark: ISENS S#:86100584
Ipsen S.A.
i-Sens, Inc.
86100571
04/15/2014
Case Western Reserve University
Mark: ISENS S#:86100571
Ipsen S.A.
i-Sens, Inc.
91215451
03/18/2015
Sunesis Pharmaceuticals, Inc.
Mark: ONCYTIQ S#:85909908
Ipsen Pharma S.A.S
Mark: ONTELRIQ S#:79129963 R#:4473154
86060212
02/27/2014
Merck Sharp & Dohme Corp.
Mark: ZUTRAVIS S#:86060212
Ipsen Pharma S.A.S.
85909908
10/14/2013
Sunesis Pharmaceuticals, Inc.
Mark: ONCYTIQ S#:85909908
Ipsen Pharma S.A.S
77628372
10/05/2011
IPSEN S.A.
Mark: IPSEN S#:77628372
77628373
09/28/2011
IPSEN S.A.
Mark: IPSEN INNOVATION FOR PATIENT CARE S#:77628373
79080475
03/09/2011
IPSEN PHARMA S.A.S.
Mark: CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIF S#:79080475
Clarient, Inc.
79080474
03/09/2011
IPSEN PHARMA S.A.S.
Mark: CLARINET S#:79080474
Clarient, Inc.
91196932
10/15/2010
Mylan Pharmaceuticals, Inc.
Mark: IPSIA S#:77877761
IPSEN S.A.; and Ipsen Pharma S.A.S.
Mark: IPSATE S#:79067203 R#:3784942
77877761
05/18/2010
Mylan Pharmaceuticals, Inc.
Mark: IPSIA S#:77877761
IPSEN S.A.
77833808
04/07/2010
Massachusetts Hospital Association, Inc.
Mark: PATIENTCARELINK S#:77833808
Ipsen SA
Page #1. 2 Next

Results as of 10/31/2020 07:45 PMSearch again
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY POLICY